Are Synthetic Cannabinoids (K2 / Spice) legal in Italy?

Legal status

Not applicable as a class status, because the class label is not the unit the Italian tables work in. The dossier's entry point is «JWH-018; AB-CHMINACA; singoli derivati e classi nominate», individual derivatives together with named classes. Article 14 of DPR 309/1990 names some compounds one at a time and defines others as a class, so some members sit inside the tables and others outside, and a compound that is neither named nor inside a named class is not caught by the family word alone. One status would be true of part of the class and false of the rest, which is why none is stated here.

Consequences if caught

Capital exposure: none. Italy has no death penalty, and the dossier's ceiling column puts the Italian maximum at a term of years rather than death or a life term. The ordinary ceiling of 30 years comes from articles 73 and 80 of DPR 309/1990 read with article 78 of the Penal Code, and article 75 handles personal use administratively, but neither track attaches to this label as a label. Exposure follows the compound identified, so a named derivative inside the tables carries the full trafficking route while one outside them carries none of it.

If prescribed or medical

Italy's country level rule, in the dossier's own terms, is that a traveller certificate list or a prescribing summary is not a substitute for the statutory tables, and that acquisition or possession for personal use runs under article 75 of DPR 309/1990 as an administrative matter rather than under the trafficking article. Attached to synthetic cannabinoids, that rule meets a set of placements rather than one, because the tables name individual compounds and expressly defined classes. Whether a prescription concept even applies depends on the member, and for the research compounds sold under this label it does not apply at all. The dossier sets out no Italian certificate list for travellers, so no route is stated here for any member of the class.

Documentation

Carry nothing sold as a synthetic cannabinoid blend, because the member decides the answer and the blend does not disclose its member. The instrument is DPR 309/1990, its enumerating provision is article 14, and the Ministry of Health compilation of the tables and its ministerial amendment index were searched on 18 September 2026 without producing a placement for this row. Classification changes by decree published in the Gazzetta Ufficiale rather than by a travel or prescribing summary, and the amendment horizon checked includes the 2026 update that added the nitazene class. The dossier's entry point for this row names JWH-018 and AB-CHMINACA alongside individually listed derivatives and expressly defined classes, which is what makes the label member specific.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Italy’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.